Literature DB >> 7775382

Site-specific glycosylation of bovine butyrophilin.

T Sato1, K Takio, A Kobata, D E Greenwalt, K Furukawa.   

Abstract

Our previous studies showed that the N-linked sugar chains of most bovine glycoproteins from milk fat globule membranes (MFGM) contain the GalNAc beta 1-->4GlcNAc group [Sato et al. (1993) J. Biochem. 114, 890-900]. Since expression of the disaccharide structure is influenced by peptide sequences near the glycosylation sites [Smith and Baenziger (1992) Proc. Natl. Acad. Sci. USA 89, 329-333], the site-specificity of the N-acetylgalactosaminylated sugar chains was investigated using bovine butyrophilin, a major MFGM glycoprotein with known primary structure. Two glycopeptide fragments which contained the N-linked sugar chains linked to either Asn-55 or Asn-215 residue were obtained by digestion of the protein with Achromobacter protease I. The sugar chains released from each glycopeptide by hydrazinolysis were reduced with NaB3H4. Structural analyses of the oligosaccharides by sequential exoglycosidase digestion and methylation analysis revealed that only complex-type sugar chains with the GalNAc beta 1-->4GlcNAc structure are included in Asn-55-linked oligosaccharides, while only novel hybrid-type sugar chains detected previously in bovine MFGM glycoproteins are included in Asn-215-linked oligosaccharides. The results show that the glycosylation of butyrophilin occurs in a site-specific manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775382     DOI: 10.1093/oxfordjournals.jbchem.a124702

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Regulation of expression of the human beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2) by Ets transcription factors.

Authors:  W Zhang; L Revers; M Pierce; H Schachter
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

2.  Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.

Authors:  P H van Berkel; H A van Veen; M E Geerts; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc.

Authors:  Eric I Park; Yiling Mi; Carlo Unverzagt; Hans-Joachim Gabius; Jacques U Baenziger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

4.  Novel induction of alpha-lactalbumin-mediated lacdiNAc-R expression in vivo.

Authors:  S I Do; K Y Lee; H N Kim
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

Review 5.  Developmental and hormonal regulation of protein N-glycosylation in the mammary gland.

Authors:  I K Vijay
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

6.  Structure of the O-glycopeptides isolated from bovine milk component PP3.

Authors:  B Coddeville; J M Girardet; Y Plancke; S Campagna; G Linden; G Spik
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

7.  Structures of the N-linked sugar chains in the PAS-6 glycoprotein from the bovine milk fat globule membrane.

Authors:  D H Kim; N Azuma; H Tanaka; C Kanno
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

8.  Glycome characterization of immunoglobulin G from buffalo (Bubalus bubalis) colostrum.

Authors:  L S Mamatha Bhanu; M Amano; S-I Nishimura; H S Aparna
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 2.916

9.  A test of current models for the mechanism of milk-lipid droplet secretion.

Authors:  Jaekwang Jeong; Ivonne Lisinski; Anil K G Kadegowda; Hyunsu Shin; F B Peter Wooding; Brian R Daniels; Jerome Schaack; Ian H Mather
Journal:  Traffic       Date:  2013-06-23       Impact factor: 6.215

Review 10.  Expression of LacdiNAc groups on N-glycans among human tumors is complex.

Authors:  Kiyoko Hirano; Akio Matsuda; Takashi Shirai; Kiyoshi Furukawa
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.